Min Dong1, Liang-Nan Zeng2, Li Lu1, Xiao-Hong Li3, Gabor S Ungvari4, Chee H Ng5, Ines H I Chow1, Ling Zhang6, Yuan Zhou7, Yu-Tao Xiang1. 1. Unit of Psychiatry,Faculty of Health Sciences,University of Macau,Macao SAR,China. 2. Department of Neurosurgery,The Affiliated Hospital of Southwest Medical University,Luzhou,China. 3. The National Clinical Research Center for Mental Disorders, China & Center of Depression, Beijing Institute for Brain Disorders & Mood Disorders Center, Beijing Anding Hospital, Capital Medical University,Beijing,China. 4. University of Notre Dame Australia/Marian Centre,Perth,Australia. 5. Department of Psychiatry,University of Melbourne,Melbourne, Victoria,Australia. 6. Department of Epidemiology and Health Statistics,School of Public Health, Capital Medical University & Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing,China. 7. CAS Key Laboratory of Behavioral Science & Magnetic Resonance Imaging Research Center, Institute of Psychology, Chinese Academy of Sciences,Beijing,China.
Abstract
BACKGROUND: Suicide attempt (SA), which is one of the strongest predictors of completed suicide, is common in major depressive disorder (MDD) but its prevalence across epidemiological studies has been mixed. The aim of this comprehensive meta-analysis was to examine the pooled prevalence of SA in individuals with MDD. METHODS: A systematic literature search was conducted in PubMed, Embase, PsycINFO, Web of Science and Cochrane Library from their commencement date until 27 December 2017. Original studies containing data on prevalence of SA in individuals with MDD were analyzed. RESULTS: In all, 65 studies with a total of 27 340 individuals with MDD were included. Using the random effects model, the pooled lifetime prevalence of SA was 31% [95% confidence interval (CI) 27-34%], 1-year prevalence was 8% (95% CI 3-14%) and 1-month prevalence was 24% (95% CI 15-34%). Subgroup analyses revealed that the lifetime prevalence of SA was significantly associated with the patient setting, study region and income level, while the 1-month prevalence of SA was associated with only the patient setting. CONCLUSION: This meta-analysis confirmed that SA was common in individuals with MDD across the world. Careful screening and appropriate interventions should be implemented for SA in the MDD population.
BACKGROUND: Suicide attempt (SA), which is one of the strongest predictors of completed suicide, is common in major depressive disorder (MDD) but its prevalence across epidemiological studies has been mixed. The aim of this comprehensive meta-analysis was to examine the pooled prevalence of SA in individuals with MDD. METHODS: A systematic literature search was conducted in PubMed, Embase, PsycINFO, Web of Science and Cochrane Library from their commencement date until 27 December 2017. Original studies containing data on prevalence of SA in individuals with MDD were analyzed. RESULTS: In all, 65 studies with a total of 27 340 individuals with MDD were included. Using the random effects model, the pooled lifetime prevalence of SA was 31% [95% confidence interval (CI) 27-34%], 1-year prevalence was 8% (95% CI 3-14%) and 1-month prevalence was 24% (95% CI 15-34%). Subgroup analyses revealed that the lifetime prevalence of SA was significantly associated with the patient setting, study region and income level, while the 1-month prevalence of SA was associated with only the patient setting. CONCLUSION: This meta-analysis confirmed that SA was common in individuals with MDD across the world. Careful screening and appropriate interventions should be implemented for SA in the MDD population.
Entities:
Keywords:
Major depressive disorder; meta-analysis; suicide attempt
Authors: Lisa Townsend; Rashelle Musci; Elizabeth Stuart; Kathryn Heley; Mary Beth Beaudry; Barbara Schweizer; Anne Ruble; Karen Swartz; Holly Wilcox Journal: J Adolesc Health Date: 2019-01-04 Impact factor: 5.012
Authors: Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen Journal: World Psychiatry Date: 2020-10 Impact factor: 49.548
Authors: Kari I Aaltonen; Tom Rosenström; Pekka Jylhä; Irina Holma; Mikael Holma; Sanna Pallaskorpi; Kirsi Riihimäki; Kirsi Suominen; Maria Vuorilehto; Erkki T Isometsä Journal: Front Psychiatry Date: 2020-11-26 Impact factor: 4.157
Authors: Allison C Nugent; Elizabeth D Ballard; Jessica R Gilbert; Prejaas K Tewarie; Matthew J Brookes; Carlos A Zarate Journal: Neuroimage Clin Date: 2020-08-08 Impact factor: 4.881